Govender S; Csimma C; Genant HK; Valentin-Opran A; Amit Y; Arbel R; Aro H; Atar D; Bishay M; Börner MG; Chiron P; Choong P; Cinats J; Courtenay B; Feibel R; Geulette B; Gravel C; Haas N; Raschke M; Hammacher E; Van der Velde D; Hardy P; Holt M; Josten C; Ketterl RL; Lindeque B; Lob G; Mathevon H; McCoy G; Marsh D; Miller R; Munting E; Oevre S; Nordsletten L; Patel A; Pohl A; Rennie W; Reynders P; Rommens PM; Rondia J; Rossouw WC; Daneel PJ; Ruff S; Rüter A; Santavirtal S; Schidhauer TA; Gekle C; Schnettler R; Segal D; Seiler H; Snowdowne RB; Stapert J; Taglang G; Verdonik R; Vogels L; Weckbach A; Wentzensen A; Wisriewsk T, 2002, 'Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures a prospective, controlled, randomized study of four hundred and fifty patients',
Journal of Bone and Joint Surgery, vol. 84, pp. 2123 - 2134,
http://dx.doi.org/10.2106/00004623-200212000-00001